Eastwood Bio-Medical Canada Common Stock

The latest common stock for EWOOF is $4.7M as of July 2024. That compares with $4.7M in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Eastwood Bio-Medical Canada's historical trend and sector peers before judging valuation or financial health.

Over the past year, EWOOF's common stock moved from $4.7M to $4.7M — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eastwood Bio-Medical Canada's operating scale or balance-sheet position.

A common stock figure of $4.7M for EWOOF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EWOOF's common stock ($4.7M), review year-over-year change from $4.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.